Gemcitabine and Cisplatin in Treating Patients With Refractory or Recurrent Cancer of the Cervix
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Cheryl A. Brewer, MD
University of Illinois College of Medicine at Peoria
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
34 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tom Baker Cancer Center - Calgary
Calgary, Alberta, Canada
- University of Alabama at Birmingham Comprehensive Cancer Center
Birmingham, Alabama, United States
- Rational Therapeutics Inc.
Long Beach, California, United States
- Community Hospital of Los Gatos
Los Gatos, California, United States
- Chao Family Comprehensive Cancer Center
Orange, California, United States
- Walter Reed Army Medical Center
Washington D.C., District of Columbia, United States
- H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, United States
- Rush-Presbyterian-St. Luke'S Medical Center
Chicago, Illinois, United States
- University of Illinois College of Medicine at Peoria
Peoria, Illinois, United States
- Indiana University Cancer Center
Indianapolis, Indiana, United States
- Albert B. Chandler Medical Center, University of Kentucky
Lexington, Kentucky, United States
- Tufts University School of Medicine
Boston, Massachusetts, United States
- University of Mississippi Medical Center
Jackson, Mississippi, United States
- Cooper Hospital/university Medical Center
Camden, New Jersey, United States
- Cancer Center of Albany Medical Center
Albany, New York, United States
- State University of New York Health Science Center at Brooklyn
Brooklyn, New York, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Schneider Children'S Hospital at North Shore
Manhasset, New York, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Lineberger Comprehensive Cancer Center, Unc
Chapel Hill, North Carolina, United States
- Duke Comprehensive Cancer Center
Durham, North Carolina, United States
- Comprehensive Cancer Center at Wake Forest University
Winston-Salem, North Carolina, United States
- Barrett Cancer Center, the University Hospital
Cincinnati, Ohio, United States
- Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio, United States
- Ireland Cancer Center
Cleveland, Ohio, United States
- Arthur G. James Cancer Hospital - Ohio State University
Columbus, Ohio, United States
- University of Oklahoma College of Medicine
Oklahoma City, Oklahoma, United States
- Abington Memorial Hospital
Abington, Pennsylvania, United States
- Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States
- Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
- University of Pennsylvania Cancer Center
Philadelphia, Pennsylvania, United States
- Simmons Cancer Center - Dallas
Dallas, Texas, United States
- Cancer Center at the University of Virginia
Charlottesville, Virginia, United States
- Tacoma General Hospital
Tacoma, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2000
- Primary completion
- 30 Apr 2006
- Completion
- —
- Last update posted
- 11 Apr 2013
- Registered enrollment
- —
- Registry id
- NCT00006482
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.